Diffuse Midline Glioma research hub

FIDES: Focused Ultrasound-mediated Blood-Brain Barrier Opening In Pontine Diffuse Midline Glioma (DMG) to Enhance Systemic Therapy with Temozolomide – an exploratory pilot and feasibility trial

This study looks into a new way to treat a type of brain tumour called Diffuse Midline Glioma. It uses sound waves to help a common cancer medicine, Temozolomide, reach the tumour better. This is a first step to see if it's safe and how well it works.